title: [The role of erythropoietin in improvement of wound healing].
abstract: Pleiotropic substances are characterized by their versatile and complex range of actions which makes them potential new active agents for the therapy of wounds. Besides its known effect to increase red blood cell production, the glycoprotein hormone erythropoietin (EPO) has been found to demonstrate a tissue protective effect in several other organs. The administration of EPO during skin wound healing is most likely essentially based on its cytopotective, proangiogenic, antiapoptotic and antiinflammatory effects. Herein EPO stimulates a coordinated interaction of different types of cells at a low or only a single dose. This review article aims to present the advantages and disadvantages of EPO administration in different experimental models to study the healing and regeneration processes of the skin and discusses possible clinical applications.
authors.affiliation: Klinik für Plastische, Hand- und Wiederherstellungschirurgie, Medizinische Hochschule Hannover, Deutschland. sorg.heiko@mh-hannover.de
authors.forename: H
authors.initials: H
authors.lastname: Sorg
authors.forename: J W
authors.initials: JW
authors.lastname: Kuhbier
authors.forename: B
authors.initials: B
authors.lastname: Menger
authors.forename: K
authors.initials: K
authors.lastname: Reimers
authors.forename: Y
authors.initials: Y
authors.lastname: Harder
authors.forename: P M
authors.initials: PM
authors.lastname: Vogt
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D062109:Dermatologic Surgical Procedures; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004921:Erythropoietin / Q000494:pharmacology*; D006801:Humans; D007279:Injections, Subcutaneous; D011994:Recombinant Proteins; D012038:Regeneration / Q000187:drug effects*; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin